SPESOLIMAB

SPESOLIMAB was reported 403 times

SPESOLIMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GENERALISED PUSTULAR PSORIASIS 82 0.2828
1 PARANEOPLASTIC DERMATOSIS 1 0.2000
2 KERION 1 0.0769
3 BENIGN FAMILIAL HAEMATURIA 1 0.0667
4 DERMATOLOGIC EXAMINATION ABNORMAL 1 0.0455
5 PSORIASIS AREA SEVERITY INDEX INCREASED 7 0.0424
6 PARATHYROID GLAND OPERATION 3 0.0200
7 LEIOMYOSARCOMA METASTATIC 1 0.0147
8 MEDICAL DEVICE SITE ABSCESS 1 0.0145
9 MYRINGITIS 1 0.0135
10 VEXAS SYNDROME 1 0.0104
11 INFLAMMATORY PAIN 7 0.0103
12 PALMOPLANTAR PUSTULOSIS 4 0.0076
13 HYPOBARISM 1 0.0067
14 CARDIAC PACEMAKER REPLACEMENT 3 0.0065
15 PARASPINAL ABSCESS 1 0.0065
16 PUSTULE 15 0.0063
17 RADIAL NERVE PALSY 2 0.0057
18 PUSTULAR PSORIASIS 19 0.0055
19 SKIN STRIAE 7 0.0047
20 STAPHYLOCOCCAL SCALDED SKIN SYNDROME 1 0.0044
21 INFESTATION 1 0.0039
22 LEUKAEMOID REACTION 1 0.0038
23 SACROILIITIS 7 0.0037
24 LYMPHOMATOID PAPULOSIS 1 0.0034
25 DEVICE RELATED BACTERAEMIA 1 0.0032
26 EXCESSIVE CERUMEN PRODUCTION 2 0.0032
27 MUSCLE ABSCESS 2 0.0032
28 WOUND INFECTION PSEUDOMONAS 1 0.0032
29 BREAST SWELLING 7 0.0026
30 PROCEDURAL HEADACHE 1 0.0024
31 CORNEAL DYSTROPHY 1 0.0024
32 DERMATITIS EXFOLIATIVE GENERALISED 8 0.0023
33 ADRENAL NEOPLASM 1 0.0021
34 FAECAL VOLUME DECREASED 1 0.0021
35 SPONDYLITIS 7 0.0019
36 OCCIPITAL NEURALGIA 1 0.0018
37 DERMATOSIS 1 0.0016
38 ABDOMINAL WALL ABSCESS 1 0.0015
39 NONINFECTIVE GINGIVITIS 2 0.0014
40 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
41 SOLAR LENTIGO 1 0.0011
42 KLEBSIELLA BACTERAEMIA 1 0.0011
43 INJECTION SITE SCAB 1 0.0010
44 LYMPHADENECTOMY 1 0.0010
45 EPIDIDYMITIS 1 0.0009
46 CARDIAC DEATH 1 0.0008
47 SKIN FRAGILITY 2 0.0008
48 POST-ACUTE COVID-19 SYNDROME 1 0.0008
49 MAST CELL ACTIVATION SYNDROME 1 0.0007
50 STAPHYLOCOCCAL BACTERAEMIA 3 0.0007
51 PULMONARY SEPSIS 1 0.0007
52 IMMUNE-MEDIATED MYOCARDITIS 1 0.0006
53 COSTOCHONDRITIS 1 0.0006
54 OPPORTUNISTIC INFECTION 1 0.0005
55 INJECTION SITE CELLULITIS 1 0.0005
56 LIP DISORDER 1 0.0005
57 HYPOPROTEINAEMIA 1 0.0005
58 GINGIVAL RECESSION 1 0.0005
59 DEVICE RELATED SEPSIS 1 0.0005
60 EYE CONTUSION 1 0.0005
61 SLEEP DEFICIT 1 0.0005
62 BLOOD CREATINE INCREASED 2 0.0005
63 URINARY TRACT DISORDER 2 0.0004
64 DISTRIBUTIVE SHOCK 1 0.0004
65 ESCHERICHIA BACTERAEMIA 1 0.0004
66 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 1 0.0004
67 LYMPHADENITIS 1 0.0004
68 INFREQUENT BOWEL MOVEMENTS 1 0.0004
69 PNEUMOCYSTIS JIROVECII PNEUMONIA 4 0.0004
70 DRUG TOLERANCE 2 0.0004
71 ENDODONTIC PROCEDURE 1 0.0004
72 APPENDICITIS PERFORATED 1 0.0004
73 ENDOCARDITIS 2 0.0004
74 SKIN WRINKLING 1 0.0004
75 INVASIVE DUCTAL BREAST CARCINOMA 1 0.0004
76 NEUTROPHILIA 2 0.0004
77 DUODENAL ULCER HAEMORRHAGE 1 0.0003
78 SKIN ATROPHY 2 0.0003
79 BLOOD CULTURE POSITIVE 1 0.0003
80 INFUSION SITE EXTRAVASATION 2 0.0003
81 BACTERIAL SEPSIS 1 0.0003
82 CARDIAC FAILURE ACUTE 2 0.0003
83 THROMBOPHLEBITIS 1 0.0003
84 BRONCHIOLITIS 1 0.0003
85 HAEMORRHAGIC DIATHESIS 1 0.0003
86 SKIN WEEPING 1 0.0003
87 PYODERMA GANGRENOSUM 1 0.0003
88 CLAVICLE FRACTURE 1 0.0003
89 THYROID MASS 1 0.0003
90 FAECES HARD 1 0.0003
91 GALLBLADDER OPERATION 1 0.0002
92 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
93 ARTHRITIS BACTERIAL 1 0.0002
94 ANAPHYLACTOID REACTION 1 0.0002
95 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
96 HYPERPYREXIA 1 0.0002
97 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
98 SUSPECTED OFF LABEL USE 1 0.0002
99 HIDRADENITIS 2 0.0002
100 SKIN LESION 6 0.0002
101 UROSEPSIS 2 0.0002
102 ROSACEA 1 0.0002
103 ERYTHEMA MULTIFORME 2 0.0002
104 FLANK PAIN 2 0.0002
105 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
106 STAPHYLOCOCCAL SEPSIS 1 0.0002
107 INFLAMMATORY MARKER INCREASED 1 0.0002
108 VEIN DISORDER 1 0.0002
109 PERIORBITAL OEDEMA 1 0.0002
110 BLOOD LACTIC ACID INCREASED 1 0.0002
111 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
112 NONSPECIFIC REACTION 1 0.0002
113 MICTURITION URGENCY 2 0.0002
114 MYOCARDITIS 2 0.0002
115 PSORIATIC ARTHROPATHY 7 0.0002
116 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
117 ENERGY INCREASED 1 0.0002
118 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 12 0.0002
119 HEPATITIS B 1 0.0002
120 SWELLING OF EYELID 1 0.0002
121 LIVER DISORDER 7 0.0002
122 MATERNAL EXPOSURE DURING PREGNANCY 14 0.0002
123 IMMUNE SYSTEM DISORDER 2 0.0002
124 MENINGITIS 1 0.0001
125 DERMATITIS 3 0.0001
126 PAPULE 1 0.0001
127 RASH PUSTULAR 1 0.0001
128 SKIN HAEMORRHAGE 2 0.0001
129 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
130 HEPATOCELLULAR CARCINOMA 1 0.0001
131 TROPONIN INCREASED 1 0.0001
132 HYPERTHERMIA 1 0.0001
133 ACIDOSIS 1 0.0001
134 BOWEL MOVEMENT IRREGULARITY 1 0.0001
135 PROCEDURAL COMPLICATION 1 0.0001
136 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
137 HYPOALBUMINAEMIA 1 0.0001
138 AFFECTIVE DISORDER 1 0.0001
139 ARTHRITIS 10 0.0001
140 FURUNCLE 1 0.0001
141 PSORIASIS 16 0.0001
142 EOSINOPHIL COUNT INCREASED 1 0.0001
143 INFUSION SITE ERYTHEMA 1 0.0001
144 FACIAL PARALYSIS 1 0.0001
145 HYSTERECTOMY 1 0.0001
146 PAIN OF SKIN 3 0.0001
147 WOUND 3 0.0001
148 NEPHROPATHY 1 0.0001
149 ABORTION INDUCED 1 0.0001
150 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
151 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
152 BODY TEMPERATURE DECREASED 1 0.0001
153 HOSPICE CARE 1 0.0001
154 BRAIN INJURY 1 0.0001
155 PRODUCT ADMINISTRATION ERROR 2 0.0001
156 HYPOTHERMIA 1 0.0001
157 DECREASED ACTIVITY 1 0.0001
158 IMPAIRED HEALING 3 0.0001
159 ASPIRATION 1 0.0001
160 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
161 SKIN DISORDER 3 0.0001
162 SKIN INFECTION 1 0.0001
163 INTESTINAL PERFORATION 1 0.0001
164 REBOUND EFFECT 1 0.0001
165 DERMATITIS CONTACT 1 0.0001
166 INTERNAL HAEMORRHAGE 1 0.0001
167 METASTASES TO LUNG 1 0.0001
168 ELECTROLYTE IMBALANCE 1 0.0001
169 SKIN EXFOLIATION 7 0.0001
170 THERAPEUTIC RESPONSE DECREASED 5 0.0001
171 SPINAL OPERATION 1 0.0001
172 HYPERCALCAEMIA 1 0.0001
173 SEPSIS 9 0.0001
174 PNEUMONIA ASPIRATION 2 0.0001
175 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
176 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
177 INFLAMMATION 4 0.0001
178 TACHYPNOEA 1 0.0001
179 HEPATIC ENZYME INCREASED 5 0.0001
180 GINGIVAL BLEEDING 1 0.0001
181 ANAPHYLACTIC REACTION 4 0.0001
182 ORAL DISCOMFORT 1 0.0001
183 HYPOMAGNESAEMIA 1 0.0001
184 BLISTER 4 0.0001
185 URINARY TRACT INFECTION 12 0.0001
186 INTENTIONAL DOSE OMISSION 2 0.0001
187 BRONCHOSPASM 1 0.0001
188 APATHY 1 0.0001
189 DRUG-INDUCED LIVER INJURY 2 0.0001
190 DEEP VEIN THROMBOSIS 4 0.0001
191 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 11 0.0001
192 METASTASES TO BONE 1 0.0001
193 STAPHYLOCOCCAL INFECTION 2 0.0001
194 GAIT INABILITY 2 0.0001
195 CELLULITIS 3 0.0001
196 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
197 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
198 ILLNESS 6 0.0001
199 ECZEMA 3 0.0001
200 PRURITUS 22 0.0001
201 RASH MACULAR 2 0.0001
202 EOSINOPHILIA 1 0.0001
203 AMENORRHOEA 1 0.0001
204 METASTASES TO LIVER 1 0.0001
205 DRUG ERUPTION 1 0.0001
206 SKIN BURNING SENSATION 4 0.0001
207 OSTEOMYELITIS 1 0.0001
208 HYPERGLYCAEMIA 2 0.0001
209 RESPIRATORY FAILURE 4 0.0001
210 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
211 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
212 HYPOCALCAEMIA 1 0.0001
213 LETHARGY 3 0.0001
214 EAR PAIN 1 0.0001
215 SKIN FISSURES 1 0.0001
216 CARDIAC FAILURE 4 0.0000
217 ERYTHEMA 10 0.0000
218 HYPOACUSIS 2 0.0000
219 RHINORRHOEA 3 0.0000
220 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
221 FAECES DISCOLOURED 1 0.0000
222 SWELLING FACE 3 0.0000
223 SEPTIC SHOCK 2 0.0000
224 RASH 20 0.0000
225 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
226 PULMONARY OEDEMA 2 0.0000
227 THROAT IRRITATION 2 0.0000
228 THERAPY NON-RESPONDER 2 0.0000
229 PANCREATITIS ACUTE 1 0.0000
230 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
231 MUSCLE TWITCHING 1 0.0000
232 HYPOKALAEMIA 2 0.0000
233 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
234 SWELLING 4 0.0000
235 DEVICE MALFUNCTION 3 0.0000
236 DISEASE RECURRENCE 2 0.0000
237 RASH ERYTHEMATOUS 2 0.0000
238 BLOOD GLUCOSE DECREASED 2 0.0000
239 DRUG INTOLERANCE 4 0.0000
240 NEURALGIA 1 0.0000
241 DRUG INEFFECTIVE 54 0.0000
242 INJECTION SITE URTICARIA 1 0.0000
243 LIVER INJURY 1 0.0000
244 BRONCHITIS 3 0.0000
245 WEIGHT INCREASED 9 0.0000
246 HEPATITIS 1 0.0000
247 PERIPHERAL SWELLING 6 0.0000
248 DRUG RESISTANCE 1 0.0000
249 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
250 ANAPHYLACTIC SHOCK 1 0.0000
251 UNRESPONSIVE TO STIMULI 1 0.0000
252 SKIN ULCER 1 0.0000
253 RESPIRATORY TRACT INFECTION 1 0.0000
254 EAR INFECTION 1 0.0000
255 PYREXIA 13 0.0000
256 FEAR 1 0.0000
257 PNEUMONITIS 1 0.0000
258 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
259 INFLUENZA LIKE ILLNESS 3 0.0000
260 CARDIAC ARREST 3 0.0000
261 RESPIRATORY ARREST 1 0.0000
262 RESPIRATORY DISTRESS 1 0.0000
263 ABNORMAL DREAMS 1 0.0000
264 INFLUENZA 4 0.0000
265 RENAL IMPAIRMENT 3 0.0000
266 ANGINA PECTORIS 1 0.0000
267 HERPES ZOSTER 2 0.0000
268 ASTHENIA 13 0.0000
269 INFECTION 5 0.0000
270 NASAL CONGESTION 2 0.0000
271 URINARY INCONTINENCE 1 0.0000
272 CATARACT 2 0.0000
273 BLOOD POTASSIUM DECREASED 1 0.0000
274 DISCOMFORT 2 0.0000
275 EPILEPSY 1 0.0000
276 LIMB DISCOMFORT 1 0.0000
277 EXPOSURE DURING PREGNANCY 2 0.0000
278 HEAD INJURY 1 0.0000
279 PULMONARY EMBOLISM 3 0.0000
280 CYSTITIS 1 0.0000
281 CHOLELITHIASIS 1 0.0000
282 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
283 BLOOD PRESSURE DECREASED 2 0.0000
284 LIP SWELLING 1 0.0000
285 FUNGAL INFECTION 1 0.0000
286 URTICARIA 5 0.0000
287 EYE PRURITUS 1 0.0000
288 OFF LABEL USE 26 0.0000
289 CONDITION AGGRAVATED 9 0.0000
290 FLUSHING 3 0.0000
291 INJECTION SITE PAIN 9 0.0000
292 DELIRIUM 1 0.0000
293 COVID-19 5 0.0000
294 HEART RATE DECREASED 1 0.0000
295 HYPOXIA 1 0.0000
296 LYMPHADENOPATHY 1 0.0000
297 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
298 ACCIDENTAL OVERDOSE 1 0.0000
299 DYSURIA 1 0.0000
300 EYE SWELLING 1 0.0000
301 HEPATIC FUNCTION ABNORMAL 1 0.0000
302 DYSPNOEA EXERTIONAL 1 0.0000
303 ARTHRALGIA 11 0.0000
304 HOSPITALISATION 4 0.0000
305 INJECTION SITE BRUISING 2 0.0000
306 EXTRA DOSE ADMINISTERED 1 0.0000
307 FATIGUE 19 0.0000
308 OSTEOPOROSIS 1 0.0000
309 TREATMENT FAILURE 2 0.0000
310 POLLAKIURIA 1 0.0000
311 ROAD TRAFFIC ACCIDENT 1 0.0000
312 COLITIS ULCERATIVE 1 0.0000
313 GASTROINTESTINAL DISORDER 2 0.0000
314 INCORRECT DOSE ADMINISTERED 5 0.0000
315 MEMORY IMPAIRMENT 3 0.0000
316 SKIN DISCOLOURATION 1 0.0000
317 NASOPHARYNGITIS 4 0.0000
318 HYPERSENSITIVITY 4 0.0000
319 PRODUCTIVE COUGH 1 0.0000
320 HYPOGLYCAEMIA 1 0.0000
321 PAIN IN EXTREMITY 6 0.0000
322 HYPOTENSION 4 0.0000
323 FLUID RETENTION 1 0.0000
324 ACUTE KIDNEY INJURY 3 0.0000
325 CHEST DISCOMFORT 2 0.0000
326 NERVOUSNESS 1 0.0000
327 SPEECH DISORDER 1 0.0000
328 PARAESTHESIA 3 0.0000
329 PANCREATITIS 1 0.0000
330 DEPRESSED MOOD 1 0.0000
331 DIARRHOEA 12 0.0000
332 DISTURBANCE IN ATTENTION 1 0.0000
333 PNEUMONIA 6 0.0000
334 RASH PRURITIC 1 0.0000
335 OEDEMA 1 0.0000
336 NECK PAIN 1 0.0000
337 ABDOMINAL DISCOMFORT 3 0.0000
338 FLATULENCE 1 0.0000
339 MUSCULAR WEAKNESS 2 0.0000
340 HEADACHE 11 0.0000
341 BACK PAIN 4 0.0000
342 DYSPHONIA 1 0.0000
343 CHILLS 2 0.0000
344 WHEEZING 1 0.0000
345 IRRITABILITY 1 0.0000
346 JOINT SWELLING 2 0.0000
347 ILL-DEFINED DISORDER 1 0.0000
348 PLEURAL EFFUSION 1 0.0000
349 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
350 INJECTION SITE ERYTHEMA 2 0.0000
351 GAIT DISTURBANCE 3 0.0000
352 BLOOD CREATININE INCREASED 1 0.0000
353 RENAL FAILURE 2 0.0000
354 DRY SKIN 2 0.0000
355 INJECTION SITE PRURITUS 1 0.0000
356 PRODUCT QUALITY ISSUE 2 0.0000
357 ABDOMINAL PAIN UPPER 3 0.0000
358 WEIGHT DECREASED 4 0.0000
359 BURNING SENSATION 1 0.0000
360 INJURY 1 0.0000
361 HYPERTENSION 3 0.0000
362 UNDERDOSE 1 0.0000
363 MALAISE 6 0.0000
364 PRODUCT DOSE OMISSION ISSUE 4 0.0000
365 EPISTAXIS 1 0.0000
366 HALLUCINATION 1 0.0000
367 CHRONIC KIDNEY DISEASE 1 0.0000
368 INJECTION SITE SWELLING 1 0.0000
369 DECREASED APPETITE 3 0.0000
370 NAUSEA 10 0.0000
371 PROSTATE CANCER 1 0.0000
372 SUICIDAL IDEATION 1 0.0000
373 CHEST PAIN 2 0.0000
374 BREAST CANCER 1 0.0000
375 ANXIETY 3 0.0000
376 DYSPHAGIA 1 0.0000
377 MIGRAINE 1 0.0000
378 CONTUSION 1 0.0000
379 ALOPECIA 2 0.0000
380 DYSPEPSIA 1 0.0000
381 SINUSITIS 1 0.0000
382 HAEMORRHAGE 1 0.0000
383 PLATELET COUNT DECREASED 1 0.0000
384 DEATH 8 0.0000
385 THROMBOCYTOPENIA 1 0.0000
386 DEPRESSION 2 0.0000
387 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
388 ABDOMINAL PAIN 2 0.0000
389 VOMITING 4 0.0000
390 DISEASE PROGRESSION 1 0.0000
391 FEELING ABNORMAL 2 0.0000
392 OEDEMA PERIPHERAL 1 0.0000
393 PAIN 5 0.0000
394 VISUAL IMPAIRMENT 1 0.0000
395 INSOMNIA 2 0.0000
396 COUGH 2 0.0000
397 HYPOAESTHESIA 1 0.0000
398 BLOOD PRESSURE INCREASED 1 0.0000
399 FALL 2 0.0000
400 CEREBROVASCULAR ACCIDENT 1 0.0000
401 MYALGIA 1 0.0000
402 MYOCARDIAL INFARCTION 1 0.0000
403 MUSCLE SPASMS 1 0.0000
404 PRODUCT USE ISSUE 1 0.0000
405 BLOOD GLUCOSE INCREASED 1 0.0000
406 ANAEMIA 1 0.0000
407 SOMNOLENCE 1 0.0000
408 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
409 CONSTIPATION 1 0.0000
410 DIZZINESS 2 0.0000
411 DYSPNOEA 1 0.0000